4.7 Article

Activated pregnane X receptor inhibits cervical cancer cell proliferation and tumorigenicity by inducing G2/M cell-cycle arrest

Journal

CANCER LETTERS
Volume 347, Issue 1, Pages 88-97

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.01.026

Keywords

Pregnane X receptor; Cervical cancer; Proliferation; Cell cycle; Tumorigenicity

Categories

Funding

  1. Guangdong Natural Science Foundation [S2012010010955]
  2. China Postdoctoral Science Foundation [2012M510200]
  3. central government special funds supporting the development of local colleges and universities

Ask authors/readers for more resources

Pregnane X receptor (PXR) regulates cell proliferation and carcinogenesis in female reproductive tissue. We showed that PXR was expressed in cervical cells and tissue samples. PXR were lower or greatly diminished in cancer tissues compared to normal control. Functionally, activation of human PXR by rifampicin or ectopic expression of constitutively-activated human VP-PXR inhibited cervical cell proliferation. Constitutively-activated VP-PXR attenuated CaSki and HeLa xenograft tumor growth in nude mice compared with control. The cellular proliferation inhibition of PXR by causing G2/M cell-cycle arrest is involved up-regulation of Cullin1-3, MAD2L1, and down-regulation of ANAPC2 and CDKN1A. Our data suggests that PXR signaling inhibits tumor cell proliferation in vitro and cervical carcinoma growth in vivo. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available